News of the expanded cost-reduction drive came as Pfizer recorded 1% sales growth to $15 billion, driven by continued strong ...

The drug – which MSD acquired as part of its $10.8 billion takeover of Prometheus Biosciences in 2023 – is a key pipeline ...

The criteria developed by UK health technology assessment (HTA) agency NICE to decide who should be referred by GPs for ...

Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry. A Harvard ...

Pathos AI has added to its pipeline of cancer drugs by licensing a bispecific antibody-drug conjugate (ADC) for solid tumours ...

Expanded APAC expertise, enhanced global infrastructure, and AI-enabled innovation help life sciences organizations generate actionable insights from every scientific interaction. PHILADELPHIA, PA – ...

Under the terms of the deal, ‌Lantheus' shareholders will get $102.50 per share in cash when the deal closes, along with the ...

The last mega-mergers between big pharma companies were BMS' $74 billion deal with Celgene in 2019 and the $63 billion AbbVie ...

Novartis paid out $195 million in 2020 to settle a criminal claim brought by the federal government – at the time, the ...

Supernus Pharma and Indivior have signed an all-stock merger agreement that would establish a new company, focused on central ...

Analysts said the ZEUS failure makes ziltivekimab a high-risk asset and increases the pressure on Novo Nordisk to carry out ...

Sanofi is reported to be preparing a move to take control of US biotech Ocular Therapeutix, after an initial bid was rejected last year. That is according to French newspaper La Lettre, which said ...